Levon Resources (LVNVF) 0.4060 $LVNVF
Levon Resources Ltd. Announces New Special Meeting Date
Marketwired - Wed Apr 29, 4:54PM CDT
Levon Resources Ltd. ("Levon"

(TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) announced today that it has rescheduled the special meeting (the "Meeting"

of shareholders and optionholders of Levon (together, the "Levon Securityholders"

, which was initially called for May 27, 2015, in connection with the previously announced arrangement (the "Arrangement"

between Levon, SciVac Ltd. and 1027949 B.C. Ltd. Levon gave notice today that the Meeting will be held on Wednesday, June 3, 2015. The record date for the Meeting has not changed, being April 24, 2015. Specific details in respect of the Arrangement and the Meeting, including the location of the Meeting, will be contained in a management information circular of Levon, which is expected to be mailed on or about May 7, 2015 to Levon Securityholders of record on April 24, 2015.
LVN.TO: 0.49 (+0.04)
Pershing Gold, A Unique Mingling Of The Resource And Biotech Worlds
Atlas Grinned - at Seeking Alpha - Tue Apr 21, 10:19AM CDT
Opko and its CEO Dr. Phillip Frost Add MabVax to Their Portfolios
ACCESSWIRE - Mon Apr 06, 6:15PM CDT
CORAL GABLES, FL / ACCESSWIRE / April 6, 2015 / Holding companies invest in the securities of other companies all the time aiming to increase shareholder value. There are hits and there are misses, as with all investments. But Opko Health (NYSE: OPK) has been on such a hot streak in this game especially in the last few months that even relatively small deals deserve attention. Its latest move - both for Opko and for Frost's personal investment trust - is to be part of a $12M private placement into MabVax Therapeutics (OTCQB: MBVX).
OPK: 16.92 (+0.24), PFE: 33.99 (+0.05), JUNO: 43.37 (-1.52), NVCN: 6.76 (+0.26)
OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources
Business Wire - Mon Mar 23, 8:06AM CDT
OPKO Health, Inc. (NYSE: OPK) announced today that SciVac Ltd. ("SciVac"

, an Israeli entity in which OPKO has a forty-five percent ownership interest, has entered into an agreement pursuant to which Levon Resources Ltd. (LVN.TO)(OTC:LVNVF)(LO9.F) will acquire 100% of the issued and outstanding ordinary shares of SciVac by way of a court-approved plan of arrangement (the "Arrangement"

. Upon closing, Levon intends to change its name to SciVac Inc. ("New SciVac"

, and the current officers and directors of SciVac will be the officers and directors of New SciVac post-closing. The current owners of SciVac will own 68.4% of the outstanding shares of New SciVac post-closing, with OPKO owning approximately 30% of the outstanding shares.
OPK: 16.92 (+0.24)
Opko's Frost Inks Levon Deal with Israel's SciVac, a Hint for the Next Merger?
ACCESSWIRE - Fri Mar 20, 10:30AM CDT
NEW YORK, NY / ACCESSWIRE / March 20, 2015 / On September 11 last year, a little-known Israeli financial magazine called Globes came out with a report that Dr. Phillip Frost, Chairman and CEO of Opko Health (NYSE:OPK), and then Chairman of Teva Pharmaceuticals (NYSE:TEVA), was interested in moving a private Israeli biotech called SciVac, 45% owned by Opko, into a corporate shell and making it public.
OPK: 16.92 (+0.24), TEVA: 60.23 (-0.99)
Levon Resources Ltd. Announces Definitive Agreement to Acquire SciVac Ltd.
Marketwired - Fri Mar 20, 8:33AM CDT
Levon Resources Ltd. ("Levon"

(TSX: LVN) (FRANKFURT: LO9) (OTCQX: LVNVF) and SciVac Ltd. ("SciVac"

announced today that they have entered into an arrangement pursuant to which Levon will acquire 100% of the issued and outstanding ordinary shares of SciVac by way of a court-approved plan of arrangement (the "Arrangement"

.
OPK: 16.92 (+0.24), LVN.TO: 0.49 (+0.04)
IIROC Trade Resumption - Levon Resources Ltd.
Newsfile Corp - Fri Mar 20, 7:43AM CDT
Trading resumes in:
IIROC Trade Halt - Levon Resources Ltd.
Newsfile Corp - Fri Mar 20, 7:41AM CDT
The following issues have been halted by IIROC:
Levon Responds to Recent Trading Activity
Marketwired - Mon Mar 02, 8:40AM CST
Levon Resources Ltd. ("Levon" or the "Company"

(TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) is issuing this press release at the request of Market Surveillance at IIROC on behalf of the Toronto Stock Exchange. Levon confirms that while no material change has occurred in the Company's business or operations, the Company is in discussions with a non-resources issuer regarding a proposed corporate transaction. There can be no assurance that these discussions will result in a transaction, or on what terms. Until such time as a transaction has been agreed, at which time the Company will provide full information, the Company does not intend to make any further comment on this matter.
LVN.TO: 0.49 (+0.04)
Levon Announces Closing of USD$1 Million Private Placement
Marketwired - Tue Nov 04, 3:53PM CST
Levon Resources Ltd. ("Levon" or the "Company"

(TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) is pleased to announce that it has closed the private placement (the "Placement"

that was announced on October 24, 2014. Pursuant to the Placement, Levon issued 4,400,000 common shares at a price of CAD$0.25 per share for gross proceeds of USD$1,000,000. The common shares sold in the Placement are subject to a four month hold period under applicable Canadian securities laws which expires on March 5, 2015.
LVN.TO: 0.49 (+0.04)
Levon Resources Ltd. Announces a USD $1 Million Private Placement
Marketwired - Fri Oct 24, 7:01AM CDT
Levon Resources Ltd. (the Company) (TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) is pleased to announce it is undertaking a USD $1 million private placement (the "Placement"

.
LVN.TO: 0.49 (+0.04)
Levon Announces Closing of USD$5.4 Million Private Placement
Marketwired - Tue Oct 21, 2:27PM CDT
Levon Resources Ltd. ("Levon" or the "Company"

(TSX: LVN)(OTCQX: LVNVF)(BERLIN: LO9)(FRANKFURT: LO9) is pleased to announce that it has closed the private placement with a group of U.S. investors including Dr. Philip Frost, Barry Honig and Michael Brauser (the "Placement"

that was announced on October 15, 2014. Pursuant to the Placement, Levon issued 27,000,000 common shares at a price of CAD$0.22 per share for gross proceeds of USD$5,400,000. The common shares sold in the Placement are subject to a four month hold period under applicable Canadian securities laws which expires on February 22, 2015.
LVN.TO: 0.49 (+0.04)